{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:23:27Z","timestamp":1779110607091,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ad.2016.12.005","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T00:00:36Z","timestamp":1488499236000},"page":"400-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Enfermedad xantogranulomatosa orbitaria del adulto. Formas cl\u00ednicas, evaluaci\u00f3n y manejo"],"prefix":"10.1016","volume":"108","author":[{"given":"J.M.","family":"Ortiz Salvador","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Subiabre Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"P\u00e9rez Ferriols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2016.12.005_bib0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2005.085894","article-title":"Adult xanthogranulomatous disease of the orbit and ocular adnexa: New immunohistochemical findings and clinical review","volume":"90","author":"Sivak-Callcott","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ad.2016.12.005_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.det.2015.03.010","article-title":"Adult orbital xanthogranulomatous disease. A review with emphasis on etiology, systemic associations, diagnostic tools, and treatment","volume":"33","author":"Kerstetter","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2016.12.005_bib0015","first-page":"3257","article-title":"Erdheim-Chester disease: A comprehensive review","volume":"34","author":"Abdelfattah","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ad.2016.12.005_bib0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ad.2016.12.005_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/01676830.2013.842252","article-title":"Raised numbers of IgG4-positive plasma cells are a common histopathological finding in orbital xanthogranulomatous disease","volume":"33","author":"Verdijk","year":"2014","journal-title":"Orbit"},{"key":"10.1016\/j.ad.2016.12.005_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.oftal.2012.11.007","article-title":"Necrobiotic xanthogranuloma. Differential diagnosis, treatment and systemic involvement. Case report","volume":"89","author":"Sanz-Marco","year":"2014","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.ad.2016.12.005_bib0035","first-page":"5","article-title":"Evaluation of clinicopathologic characteristics and the BRAF V600E mutation in Erdheim-Chester disease among Chinese adults","volume":"74","author":"Cao","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ad.2016.12.005_bib0040","doi-asserted-by":"crossref","first-page":"xi","DOI":"10.1016\/j.det.2015.10.002","article-title":"BRAF mutations in Erdheim-Chester disease","volume":"34","author":"Campochiaro","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2016.12.005_bib0045","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1182\/blood-2010-10-313510","article-title":"Systemic perturbation of cytokine and chemokine networks in Erdheim-Chester disease: A single-center series of 37 patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ad.2016.12.005_bib0050","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood-2013-02-482984","article-title":"Detection of an NRAS mutation in Erdheim-Chester disease","volume":"122","author":"Diamond","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ad.2016.12.005_bib0055","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/archdermatol.2011.279","article-title":"A case of adult-onset asthma with periocular xanthogranulomas","volume":"147","author":"Agi","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2016.12.005_bib0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/IOP.0b013e31827ae96a","article-title":"Adult-onset asthma associated with periocular xanthogranuloma: New diagnostic and therapeutic approaches in a very rare systemic disease","volume":"29","author":"London","year":"2013","journal-title":"Ophthal Plast Reconstr Surg."},{"key":"10.1016\/j.ad.2016.12.005_bib0065","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1182\/blood-2011-05-356907","article-title":"Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy","volume":"118","author":"Szalat","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ad.2016.12.005_bib0070","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1200\/JCO.2010.32.4921","article-title":"Necrobiotic xanthogranuloma associated with immunoglobulin M paraproteinemia in a patient with Waldenstr\u00f6m macroglobulinemia","volume":"29","author":"Balagula","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2016.12.005_bib0075","doi-asserted-by":"crossref","unstructured":"Lam K, Brownstein S, Jordan DR, van der Jagt R, Jastrzebski A, Dionne MA. Bilateral necrobiotic xanthogranuloma of the eyelids followed by a diagnosis of multiple myeloma 20 years later. Ophthal Plast Reconstr Surg. 2013;29:e119-e120","DOI":"10.1097\/IOP.0b013e318279fdef"},{"key":"10.1016\/j.ad.2016.12.005_bib0080","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.revmed.2014.04.007","article-title":"Maladie d\u2019Erdheim-Chester","volume":"35","author":"Haroche","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ad.2016.12.005_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","article-title":"Erdheim-Chester disease: A systematic review","volume":"95","author":"Cives","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ad.2016.12.005_bib0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jaad.2015.11.007","article-title":"Cutaneous manifestations of Erdheim-Chester disease (ECD): Clinical, pathological, and molecular features in a monocentric series of 40 patients","volume":"74","author":"Chasset","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2016.12.005_bib0095","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/01676830701804057","article-title":"Necrobiotic xanthogranuloma occurring in an eyelid scar","volume":"27","author":"Rayner","year":"2008","journal-title":"Orbit"},{"key":"10.1016\/j.ad.2016.12.005_bib0100","doi-asserted-by":"crossref","unstructured":"Rubinstein TJ, Mehta MP, Schoenfield L, Perry JD. Orbital xanthogranuloma in an adult patient with xanthelasma palpebrarum and hypercholesterolemia. Ophthal Plast Reconstr Surg. 2014;30:e6-e8","DOI":"10.1097\/IOP.0b013e3182873d13"},{"key":"10.1016\/j.ad.2016.12.005_bib0105","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bjo.2006.107821","article-title":"Periorbital xanthogranuloma after blepharoplasty","volume":"91","author":"Zoumalan","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ad.2016.12.005_bib0110","series-title":"[Erdheim-Chester disease, an incredible simulator. Cases reports and review of literature]. Neurocirugia (Astur) [Internet]","author":"Rasc\u00f3n-Ram\u00edrez","year":"2016"},{"key":"10.1016\/j.ad.2016.12.005_bib0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.iop.0000192645.24814.e8","article-title":"Local corticosteroid treatment of eyelid and orbital xanthogranuloma","volume":"22","author":"Elner","year":"2016","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.ad.2016.12.005_bib0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/IOP.0b013e3181bd4356","article-title":"Failure of radiation therapy in orbital xanthogranuloma","volume":"26","author":"Ebrahimi","year":"2010","journal-title":"Ophthal Plast Reconstr Surg."},{"key":"10.1016\/j.ad.2016.12.005_bib0125","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bjo.2006.109587","article-title":"Management of orbital xanthogranuloma with methotrexate","volume":"91","author":"Hayden","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ad.2016.12.005_bib0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dth.12135","article-title":"Treatment of refractory necrobiotic xanthogranulomas with extracorporeal photopheresis and intravenous immunoglobulin","volume":"27","author":"Liszewski","year":"2014","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2016.12.005_bib0135","first-page":"678","article-title":"Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy","volume":"11","author":"Ghani","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ad.2016.12.005_bib0140","first-page":"680","article-title":"Immunomodulatory drugs for the treatment of periorbital necrobiotic xanthogranuloma","volume":"11","author":"Abdul-Hay","year":"2013","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ad.2016.12.005_bib0145","first-page":"298","article-title":"Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: A case report and review of the literature","volume":"11","author":"Efebera","year":"2011","journal-title":"CLML"},{"key":"10.1016\/j.ad.2016.12.005_bib0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2298\/VSP140915037P","article-title":"Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis","volume":"73","author":"Peri\u0107","year":"2016","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.ad.2016.12.005_bib0155","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1182\/blood-2015-09-672667","article-title":"Variability in the efficacy of the IL1 receptor antagonist anakinra for treating Erdheim-Chester disease","volume":"127","author":"Cohen-Aubart","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ad.2016.12.005_bib0160","doi-asserted-by":"crossref","unstructured":"Haroche J, Cohen-Aubart F, Emile JF, Maksud P, Drier A, Toledano D, et al. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease. J Clin Oncol. 2015;33:411-418.","DOI":"10.1200\/JCO.2014.57.1950"},{"key":"10.1016\/j.ad.2016.12.005_bib0165","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3109\/0284186X.2015.1120885","article-title":"Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies","volume":"55","author":"Franconieri","year":"2016","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ad.2016.12.005_bib0170","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ad.2016.12.005_bib0175","first-page":"5","article-title":"Efficacy of zoledronic acid in Erdheim-Chester disease: A case report","volume":"201","author":"Poiroux","year":"2016","journal-title":"J Bone Spine"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017300431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017300431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:05:26Z","timestamp":1757552726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731017300431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0001731017300431"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2016.12.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enfermedad xantogranulomatosa orbitaria del adulto. Formas cl\u00ednicas, evaluaci\u00f3n y manejo","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}